FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2863-2865 December 30, 2004 Number 27 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Gragoudas, E. S. PubMed Citation

Neovascularization leads to blindness in a large number of ocular disorders, most notably age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity, and other vascular occlusive diseases. Various versions of scatter-photocoagulation (laser) treatment in the peripheral retina have been shown to reduce the loss of vision that results from retinal vascular diseases but not from age-related macular degeneration.^1,2,3 For example, scatter photocoagulation, along with vitrectomy when necessary, can reduce the risk of blindness in eyes with retinal neovascularization from diabetic retinopathy by 90 percent.⁴ Current treatments for the neovascular complications of age-related macular degeneration are nowhere near this effective, with the . . . [Full Text of this Article]

Source Information

From the National Institutes of Health, Bethesda, Md.

This article has been cited by other articles:

• Li, B., Yin, W., Hong, X., Shi, Y., Wang, H.-S., Lin, S.-F., Tang, S.-B. (2008). Remodeling Retinal Neovascularization by ALK1 Gene Transfection In Vitro. IOVS 49: 4553-4560 [Abstract] [Full Text]